Mind the tax! Samir Arora alerts Indian investors…

[ad_1] At a time when Indian investors are increasingly tempted to invest in US stocks through Portfolio Management Services (PMS), where professional fund managers invest on their behalf, Samir Arora, founder and fund manager of…

Weight loss drug ‘Ozempic’ approved for use in…

[ad_1] India has officially approved the use of Ozempic (semaglutide), a once-a-week injection designed for adults with type 2 diabetes. Approved by the Central Drugs Standard Control Organisation (CDSCO), this drug has made headlines worldwide…

Tata Capital IPO: 10 key risks you should…

[ad_1] Tata Capital, the Tata Group NBFC initial public offering (IPO), is set to open for bidding on Monday, October 6, and will remain available to investors until Wednesday, October 8.The company aims to raise…

Ozempic approved for use in India: All you…

[ad_1] In a major development for diabetes management and weight loss, India’s drug regulator Central Drugs Standard Control Organisation (CDSCO) has approved Ozempic (semaglutide) for use in adults with type 2 diabetes. This will make…

Expert view: Jimeet Modi of SAMCO Group on…

[ad_1] Expert view: Jimeet Modi, the founder and CEO of SAMCO Group, while the Indian stock market exhibited muted performance in the first half of the financial year (H1FY26), the second half (H2FY26) could spring…